ORGS Stock, Orgenesis Inc. Information

Orgenesis Inc. is a fully integrated biopharmaceutical company focused on developing a trans differentiation technology for diabetes and vertically integrating manufacturing that can optimize its abilities to scale up technologies for clinical trials and eventual commercialization, but also to apply disciplined execution to emerging technologies of other cell therapy markets in such areas as cell based cancer immunotherapies and neurodegenerative diseases. This integrated approach supports the Company s business philosophy of bringing to market significant life improving medical treatments.